From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

APHL-CDC Continue Partnership to Strengthen Public Health Labs Internationally

by Global Biodefense Staff
March 12, 2017
NIAID Researcher Conducts Infectious Disease Research Under the Hood

NIAID researcher conducts laboratory studies under the biosafety hood. Image: NIH/NIAID

The Association of Public Health Laboratories (APHL) and the Centers for Disease Control and Prevention (CDC) are continuing a jointly sponsored cooperative agreement program to help strengthen public health laboratories across the globe.

A national nonprofit, APHL represents state and local governmental public health laboratories monitoring and detecting health threats in the United States.

The first cooperative agreement between the US Centers for Disease Control (CDC) and APHL began in 1989. The relationship has broadened ever since and now encompasses the range of public health. APHL leverages its long history of laboratory safety training to help build local capacity in biosafety and biosecurity with international partners.

Funding for “CDC-RFA-GH16-1720 – APHL-CDC Partnership to Strengthen Public Health Laboratories Internationally” is being made available for grantees previously awarded under the program.

This continuation funding is provided from the following sources:

  • Antibiotic Resistance
  • Global Disease Detection
  • Global Health Security
  • Immunization Program – Pandemic Influenza (No-Year) (PHSSEF)
  • Influenza Planning and Response
  • International Ebola
  • International Response and Preparedness-Ebola-Reimbursable Authority
  • National Health Safety Network
  • President’s Emergency Plan for AIDS Relief (GHP)

CDC requires grantees to submit their Annual Performance Reports (APR) by April 14, 2017 which serves as the non-competing continuation application, through www.grants.gov Funding Opportunity Number: CDC-RFA-GH16-172002CONT17.

From Our Partners

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC